DHHS Eagle graphic
ASL Header
Mission Nav Button Division Nav Button Grants Nav Button Testimony Nav Button Other Links Nav Button ASL Home Nav Button
US Capitol Building
HHS Home
Contact Us
dot graphic Testimony bar

This is an archive page. The links are no longer being updated.

Testimony on Reauthorization of the Agency for Health Care Policy and Research by John M. Eisenberg, M.D.
Administrator, Agency for Health Care Policy and Research
U.S. Department of Health and Human Services

Before the House Commerce Committee, Subcommittee on Health and Environment,
April 29, 1999


Mr. Chairman, thank you for giving me the opportunity to address the Subcommittee on the programs and activities of the Agency for Health Care Policy And Research (AHCPR). AHCPR's mission is to provide good and objective science-based information that will improve decision making at all levels, from patients, to clinicians, to health care system leaders, to public and private policymakers. AHCPR's goal is to ensure in an increasingly market-based health care system that state-of-the-science information drives informed decision making.

AHCPR was established by Congress in 1989 "for the purpose of enhancing the quality, appropriateness, and effectiveness of health care services and access to care."While we have met this objective during the past nine years, we recognize that health care in 1998 is very different from 1989, and the Agency has adjusted its agenda and priorities to meet the new challenges we face, while continuing our charge set forth by Congress. Here are our priorities:

  • To ensure that clinicians, patients, health care system leaders, and policymakers have the information that will enhance quality of care.
  • To identify gaps in access to and use of health care services, achieving value for the Nation's health care dollar, and helping the market and policymakers find ways to address those gaps.

Research That Helps Patients

Mr. Chairman, before turning to our programs and the way we conduct our work, I want to emphasize that this research has already had a profound effect on the quality of care patients receive. After all, that is the bottom line for our Agency: improving patient health. A welcome side benefit, for programs over which you have jurisdiction such as Medicare and Medicaid, is that these quality improvements, in a surprising number of cases, have also led to lower costs and more appropriate use of health care resources. For example:

  • Pneumonia. Approximately 450,000 Medicare patients are hospitalized for pneumonia each year. With AHCPR support, one group of researchers developed a way for clinicians to determine which patients with pneumonia can be safely treated at home. This option avoided hospitalization entirely. Studies of health systems that have implemented this decision tool found that it not only reduces hospitalization rates (and, consequently, Medicare costs by 26% in one major hospital) but also that home treatment is preferred by many patients.
  • Diabetes. A significant advance in diabetes treatment during recent years has been the demonstration that tight control of blood sugar, using intensive management strategies, reduces the risk of long-term complications from the disease. The intensive monitoring and self-care needed to achieve this, however, is costly and time-consuming for patients and clinicians alike. AHCPR's sponsored research has helped provide the information that diabetics and their health professionals need as they choose the best long-term management strategy for each individual. For type 1 diabetics, for example, AHCPR-funded research has shown that using continuous insulin infusion, a newer mode of insulin delivery, to achieve tighter control can decrease the incidence of ketoacidosis and low blood sugar crisis.
  • Heart Attacks. About 1.5 million Americans are admitted to hospitals yearly for serious chest pain. However, of those admitted to inpatient cardiac units, only 30 percent end up with a diagnosis of threatened or confirmed myocardial infarction (MI). This means that 70 percent undergo an expensive workup before they know that they have not had a MI, which translates to more than $3 billion of unnecessary expenditures per year. One group of AHCPR-funded investigators has tested the effectiveness of a chest pain observation unit, located within a hospital emergency department, for patients experiencing a possible MI. This intervention has revealed some very positive effects: fewer heart attacks go undiagnosed compared to hospitals with only inpatient observation units; fewer patients are mistakenly sent home without being observed; there is a 55 percent reduction in hospital admission rates; and there is a 25 percent drop in the average length of stay when an exercise electrocardiogram (ECG) is added to the evaluation procedure. Savings in total hospital costs are calculated at $567 per patient. In addition, patients who receive treatment in the chest pain units are more satisfied with their care, compared to those actually admitted to inpatient cardiac units for observation.

This research has also had a significant but unexpected impact on the way that medical research is conducted and clinical decision making takes place. For example, urologists, working with researchers we funded, found new ways of determining which men with enlarged prostates should have surgery. Health services research shifted the views of clinicians by emphasizing the importance of taking into account the patient's assessment of how the prostatism affected his ability to function, and his assessment of the risk of surgery. Our work has broadened the focus for evaluating the success or outcomes of medical care from only physiologic measures (such as urinary track pressure measures) to include important clinical outcomes, such as patients' perceptions of, and preferences for, their ability to function after treatment. This research has provided the foundation for truly informed patient choice among alternative clinical treatments and higher patient satisfaction, as patients become involved to the extent they want to be in making these choices. Plus, we have funded the translation of this research into practice, and we are already seeing reduced costs along with better outcomes through partnership with urologists and their patients. We are now funding similar research in other fields, such as breast cancer and the care of children.


Health care quality is very much in the news and a major issue for the Congress. I want you to know that our Agency has played a pivotal role in the effort to improve the quality of patient care. We have worked closely with all of the major organizations committed to improving the quality of patient care, such as the American Medical Association (AMA), the Foundation for Accountability (FACCT), the National Committee for Quality Assurance (NCQA), the Joint Committee on Accreditation of Healthcare Organizations (JCAHO), and many others. And we are using every aspect of health services research to address the challenges we face.

But let me start with a basic question: what do we mean when we say "quality?" At the most basic level, quality means doing the right thing, at the right time, in the right way, for the right person. As someone who recently left clinical medicine, I am personally sensitive to the challenge clinicians face every day in knowing what the right thing is, when the right time is, and what the right way is. We are using our clinical research, often referred to as outcomes and effectiveness research, to address those three questions. And we are undertaking efforts, equally as important, to provide clinicians with the information they need most: syntheses of what we already know so that they can provide care to their patients that takes into account the latest findings.

We are working to develop better information on the quality implications of the way we organize, deliver, and reimburse health care services. We are developing the measures and tools that will help us to assess, compare, and improve the quality of care in different plans and settings. And we are working to provide you with a better sense of how quality is faring over time, much like the "leading economic indicators" that provide you with a touchstone for how the economy is faring.

We recognize that our focus on the quality and outcomes of care needs to be paired with a focus on issues related to access to that care. And we have a special responsibility to address the needs of vulnerable populations, who are most likely to face barriers to access. Our research has demonstrated that a growing percentage of the population are not offered health insurance; that of those offered health insurance, a growing number of Americans decline insurance coverage; and that even with health insurance, access to quality health care is not assured. And the reasons for this lack of access can be surprising and disturbing. For example, the Washington Post highlighted on its front page several weeks ago an AHCPR-funded study that found that primary care physicians were prepared to recommend very different courses of treatment for patients of different races and gender who outlined identical symptoms. These physicians recommended referrals for cardiac catherization only 60% as often for black patients than white patients, and there was a clear impact of gender as well. Black women were referred only 40% as often. These results are disturbing and suggest that we have a broad array of issues to address in ensuring access to quality care.

The Conduct and Planning of our Research.

Mr. Chairman, let me know turn to how we conduct and plan our research and our specific research activities. As you well know, AHCPR is not a regulatory or enforcement agency, but a scientific research agency that sponsors, conducts and translates research. We follow the same rigorous evaluation and peer review standards for awarding research grants as does the National Institutes of Health. Three-quarters of AHCPR's research funds are used to support researchers throughout the country.

Since I have been at the Agency, we have been going through an extensive planning process. We are consulting our National Advisory Council, seeking input from our stakeholders, and welcome advice from the Subcommittee. We hope that the reauthorization process will provide an opportunity to gain additional insight from you and the other witnesses at this hearing as well as strengthen the relationship between AHCPR and this Subcommittee.

The planning process has focused our priorities on four primary customers: clinicians, patients, health care systems leaders, and policymakers, each of whom need information to enhance their contribution to improve the quality of care in this country. In the rest of my testimony, I will describe how we are serving our customers with research on outcomes, quality, cost, use, and access.

Providing Information that Helps Clinicians Provide Better Care and Patients Receive Better Care

I see AHCPR's clinical research as a continuum. First, we build the science base by conducting health services research that serves as the foundation for improved care. Second, we translate and disseminate the research in a format that can be used in clinical practice. Third, we evaluate the translation and dissemination of that research to make sure that it has reached the relevant audiences and is used appropriately.

Measuring Health Outcomes

First, let me concentrate on how we serve decisionmakers with information on outcomes of clinical care. AHCPR's sponsored research attempts to answer these questions for a wide variety of medical conditions and treatments. The findings of this research have been translated into useful tools for every day clinical practice. For example, AHCPR sponsored research at John Hopkins University developed a visual function indexCthe VF-14Cthat measures the effects of cataracts on patients' ability to perform 14 everyday activities, including reading and driving. The index also allows for comparisons of patients' visual function before and after removal of a cataract.

The VF-14 index is a sensitive and reliable measure of the impact of cataracts on visual function. As a result, it can be used to help determine the value of cataract surgery for specific patients. In a study of more than 500 patients 4 months after cataract removal, changes in patients' ratings of satisfaction with their vision correlated more strongly with changes in VF-14 scores than with traditional ways of measuring changes in visual acuity. Compared with other outcome measurements, a changed VF-14 score was also the strongest predictor of changes in patients' satisfaction with their vision.

Another tool developed by AHCPR-supported research should have a great impact on the quality of care provided to patients who suffer heart problems. An outcomes project funded by AHCPR recently found that many patients with heart attacks do not receive thrombolytic therapy (drugs to dissolve clots inside coronary arteries). Another research project at the New England Medical Center led to the development of a new tool to care for patients having a heart attack. The tool estimates whether a patient is likely to benefit from potentially lifesaving treatment with thrombolytic therapy in the emergency room. The information is provided to the doctor in "real time." The tool also calculates the patient's likelihood of developing serious complications, such as hemorrhagic stroke or major bleeding, if given thrombolytic therapy.

A trial to assess whether this instrument, which plugs into an existing electrocardiograph machine, will increase the proportion of eligible patients receiving recommended treatment is in progress. The researchers are also working with the major manufacturer of EKG machines to make this tool widely available.

Understanding Variation in Health Care

AHCPR's research emphasis has been on conditions that are common, costly, and for which there is substantial variation in practice. This research includes many of the conditions that represent a major expenditure for Medicare.

The issue of variation is not new to you. Dr. John Wennberg's work has shown that medical practice varies widely in this country. AHCPR has sponsored a substantial portion of Dr. Wennberg's work in the area of prostate disease. His research team found that the rate of radical prostatectomy for Medicare patients in Clearwater, FL is nearly twice the rate in Medina, OH (the national average is 2.0 surgeries per 1000 Medicare beneficiaries while the rates in Clearwater and Medina are 2.8 and 1.5 respectively). These variations can vary region to region, State to State, or within States. For example, the rate for radical prostatectomy for Medicare patients in Baltimore, MD, is approximately three times the rate in Salisbury, MD.

Variation provides us an opportunity to study what care is appropriate, how much is enough, and what is fair. This involves understanding when variation is due to issues of uncertainty, issues of access, and issues of overuse or under use. I would like to note that variation isn't inherently bad. The research that AHCPR supports and conducts helps us understand whether variation in medical practice should be celebrated or eliminated. In some cases, variation is caused by geographical, epidemiological, or cultural preferences. For example, we expect to have a higher rate of skin cancer in the South, and therefore more treatment for skin cancer.

Outcomes researchCwhich provides the basic knowledge of what works and what doesn't workCis the foundation for all efforts to improve the quality of health care services. We can use this knowledge to determine what the right thing is, when the right time is, and what the right way is, and whether we are getting value for what we spend.

Supporting Evidence-based Practice

A key issue in variation is professional uncertainty. If clinicians don't know what works and what doesn't work, they may be inadvertently providing inappropriate or ineffective care. AHCPR supports 12 Evidence-based Practice Centers (EPCs), which provide the scientific evidence that others will use to reduce unnecessary variation by reducing uncertainty. The 12 Centers develop scientific analyses, known as "evidence reports," of the evidence of the effectiveness of a particular treatment, technology, or procedure. These analyses are then used by health care organizations, medical societies, physician practices, and others to develop their own quality improvement tools, including guidelines, quality improvement programs, and performance measures.

For example, the Agency developed an evidence report on the findings on colorectal cancer screening. The information contained in AHCPR's evidence report led to a clinical practice guideline that was developed by the American Gastroenterology Association on colorectal cancer, which in turn, contributed to Congress' decision to expand Medicare coverage for colorectal cancer screening.

An important component of AHCPR's Evidence-based Practice Initiative is collaboration. The EPC topics are nominated by public and private sector organizations which will use and help us disseminate the information. The nominators are our partners. For example, the American Academy of Pediatrics and the American Psychiatric Association nominated attention deficit/hyperactivity disorder as a topic, and they have incorporated AHCPR's evidence report into a guideline they developed. Similarly, a consortium of patient and provider groups nominated management of urinary problems in paralyzed persons as a topic, and they will also create a guideline from it. And the Health Care Financing Administration asked us to evaluate swallowing problems in the elderly to help them determine their coverage policy for this area.

Translating Research into Practice

In addition to providing information on outcomes to clinicians and patients, we want to help them use the information to enhance the quality of care provided and received. Obviously, developing the information isn't enough. We need to make sure that it is available in a useful format to anyone who needs it. To achieve that goal, AHCPR, the American Association of Health Plans, and the American Medical Association worked together to provide one-stop-shopping for best practices in clinical care. We developed the National Guideline Clearinghouse that makes clinical practice guidelines available to every clinician, health system leader, patient, and policymaker who can use a computer.

AHCPR also is looking at the effectiveness of clinical preventive services, and the potential they have for saving lives and reducing health care costs. The medical literature increasingly recognizes that some clinical preventive services provide enormous benefit. We need to know which services are most appropriate and effective for which patients and when. The Balanced Budget Act expanded Medicare coverage for prevention services. The information AHCPR develops will be invaluable to you as you deliberate about further expansions in coverage for preventive services.

As a central component of these efforts, AHCPR will support renewed activities of the U.S. Preventive Services Task Force. Their 1996 report provides clinicians with the information on the effectiveness and appropriateness of the full range of preventive careCscreening tests for the early detection of disease, advice to help people change their risky health-related behaviors, and immunizations to prevent infections. AHCPR will support major new assessments of preventive services and updates of priority topics by the Task Force. As requested in the Balanced Budget Act, the Task Force will also work with the Institute of Medicine to evaluate the implications of including new preventive services under Medicare.

Supporting the U.S. Preventive Services Task Force will continue a long and productive partnership between the government and the leading primary care medical and nursing organizations. Our activities complement the major investment being made by the Centers for Disease Control and Prevention (CDC) in the study of preventive services in

community-based settings. We look forward to working with the CDC on integrating our research in this area.

Finally, I want to thank the Subcommittee for providing the Agency with its authority to support Centers for Education and Research Therapeutics or CERTS, under the Food and Drug Administration Modernization Act. We expect to announce to announce funding for several centers before the end of this fiscal year. The CERTS will improve the effective use of medical products, such as pharmaceuticals. This new authority builds on our existing research in this area. For example, clinicians can receive the information they need to help reduce the costs of medical care through AHCPR's research on pharmaceuticals. With funding from AHCPR, Michael Fine of the University of Pittsburgh and colleagues found that using the antibiotic erythromycin for treating community-acquired pneumonia in most outpatients aged 60 and under significantly reduces treatment costs compared with the use of other antibiotics ($5.43 versus $18.51) and has no adverse effect on medical outcomes. About 600,000 of the 4 million Americans who develop community-acquired pneumonia are hospitalized each year. This research could lead to significant savings.

Improving Decisionmaking in Health Care Systems

The health care system has gone through some significant changes over the past several years. These changes have created new structures, processes, and settings in which care is delivered. These changes have also raised a number of issues such as what is the impact on quality, what happens to patients' access to services, the cost of those services, how they are used, and the outcomes of patients who use the services. For example, some of the questions we can ask are: What happens when patients are discharged quickly from the hospital? How are managed care and traditional insurance changing and how are the new arrangements affecting access to care and the quality of that care?

Unfortunately, these changes are happening quickly and we have little scientific evidence regarding their impact on the health care system, generally, and on quality specifically. AHCPR is conducting and supporting research to fill this void.

Providing Research on Market Changes

I believe that outcomes research is more than measuring the outcomes of clinical treatments. Our customers need to understand the outcomes of the organizational and financial structures in the way medical care is delivered. It isn't enough to know that clinical services are safe, effective and appropriate if the structure for delivering that care is shaky or untested.

The journal Health Affairs featured AHCPR's research that presents the first comprehensive look at what is currently happening in the health care marketplace. The articles form an invaluable evidence-based core of information for current discussions of policy options by all health care system participantsCboth public and private.

These studies, which had a 2-year turnaround from funding to report, provide fundamental knowledge about the link between the financing and delivery of health care and the quality of services. These studies empirically and rigorously examine issues of how current, incentive-driven market decisions of multiple participantsChospitals, physicians, health plans, employers, employees, and public, private and individual purchasersCdetermine who gets health care, what kind of care, how much care, who pays and how much it costs.

Supporting Research To Improve Primary Care Systems

Issues of systems of care are not strictly limited to hospitals or other institutions. We need to understand how patients gain access to the system. AHCPR is the only agency that has an expressed responsibility to study the structure and delivery of primary care services. This research is increasingly important as more care is delivered beyond the hospital walls.

More than half of all Americans are now covered by managed care plans, which often require the use of a primary care physician or gatekeeper to manage the referral of patients from primary to specialists. Access to specialists is a major concern among the public, and has been the subject of much debate. To strengthen the scientific base underpinning the referral policies of health plans, AHCPR funded ten grants on physician referrals, and will be hosting a conference in Washington this September where the results will be presented.

Preventing System Errors

AHCPR-supported research has demonstrated that the processes and systems used to provide care are often faulty and can lead to avoidable accidents. One conclusion of the research is that many of these accidents are not the fault of individuals, and therefore can be prevented by evaluating and improving the system.

In an AHCPR-funded study, Dr. Lucian Leape, a pioneer in research on how to reduce errors in medicine, estimated that the number of injuries caused by medical errors in hospitals alone could be as high as three million annually, resulting in costs as much as $200 billion each year. In his work on drug-related errors, Dr. Leape concluded that 70 percent of these errors are avoidable, and can be prevented by re-engineering the hospital systems which allowed the errors to occur. Other organizations, such as the Department of Veterans Affairs and the American Medical Association, are using this research to develop programs to reduce preventable errors.

AHCPR is also examining how changes within systems of care affect the delivery of services and their quality. The Health Resources and Services Administration (HRSA), the National Institute of Nursing Research (NINR), and AHCPR in 1996 convened a joint meeting of experts to set a research agenda on the impact of nurse staffing levels on the quality of care in hospitals. We will be supporting additional research in this area during the current fiscal year.

Developing the Science and Tools to Measure and Improve Quality

AHCPR is working to refine existing measures and develop new measures that accurately reflect the changing health care system. An important component in our effort to develop and test valid measures is to anticipate future measurement needs. The goal of our efforts is to begin to identify and develop the "next generation" of quality measures for certain conditions and population subgroupsCparticularly vulnerable populations such as the chronically illCand in the full spectrum of treatment settings such as rehabilitation and home care.

The Agency is involved in collaborative projects with private sector organizations to develop their own quality measures. For example, AHCPR research found that elderly patients who receive beta blockers following a heart attack are 43 percent less likely to die in the first 2 years following the attack than patients who do not receive this drug. That same study found that patients who receive beta blockers are rehospitalized for heart ailments 22 percent less often than those who do not get beta blockers. However, only 21 percent of eligible patients receive beta blocker therapy.

The National Committee for Quality Assurance (NCQA) used the findings of this study as the basis for changing the performance measurement for beta blocker use after acute myocardial infarction to include patients over 75 years of age in the most recent version of the Health Plan Employer Data and Information Set (HEDIS 3.0). An important component of improving the quality of health care services is giving patients the information they need to make informed choices about their health care coverage, physicians, and treatment options.

AHCPR's Consumer Assessments of Health Plans (CAHPS) survey consists of a series of questionnaires designed to be used by public- and private-sector health plans, employers, and other organizations to survey their members and employees. The information from CAHPS questionnaires, presented in the CAHPS tested report formats, can help consumers and group purchasers compare health plans and make more informed choices based on quality.

The CAHPS materials are designed for use with all types of health insurance enrollees (Medicaid and Medicare beneficiaries as well as the privately insured) and across the full range of health care delivery systems, from fee-for-service to managed care plans. In addition to a core set of items designed for use with all respondents, some additional questions are targeted for use with certain subgroups such as persons with chronic conditions or disabilities, Medicaid and Medicare beneficiaries, and families with children.

We are not suggesting that all providers and plans in every clinical setting and every region in this country be evaluated using the exact same measures. Measures and instruments should not be one-size-fits-all, but should reflect the diversity of needs and uses. We are advocating a "department store" of accepted quality measures, all based on science and validated for reliability and usefulness, where users of measures can pick the set that fits their need, whether that need is to compare health plans or providers, or to conduct a hospital quality improvement project.

Supporting Policymakers with Data and Information

Policymakers need to understand how dramatic growth of managed care, changes in private health insurance, and other dynamics of today's market-driven health care delivery system have affected, and are likely to affect, the outcomes, quality of, cost of, and access to the health care that Americans use.

Developing and Improving Information Technology

Informatics is another important tool for improving the quality of health care services. There has been an explosion in the use of information technology in medicine, such as telemedicine and computerized medical records. These technologies have greater potential to improve the quality of, outcomes of, access to, cost of, and use of care. To achieve this potential, we need research to determine what works and what doesn't work in "high tech" health care.

Informatics is an area of research that is critical to every aspect of AHCPR's work . Let me explain. First, the revolution in information technology is critical to the ability of health care delivery systems to measure and improve the quality of care that they provide their patients. They need seamless information systemsClinking administrative, financial, and clinical dataCthat can follow patients no matter where or from whom they receive care. I am delighted to note that much of the pioneering work in developing the prototypes and evaluating their usefulness in daily practice was supported by our predecessor, the National Center for Health Services Research. AHCPR has an important and continuing role to play in evaluating the impact of informatics on the cost, access, and quality of clinical care and health care systems. Last year we funded eight projects to do just that.

Second, the type of research that AHCPR conducts and supportsCto assess what works best in clinical practice and how we organize and manage the systems in which care is deliveredCrelies upon information technology at every step. The type of rapid analysis and dissemination of data on patient outcomes envisioned by some of the quality of care proposals under consideration by the Congress will not be possible if we do not advance the state of the technology and develop the common language that will let systems from various providers, plans, purchasers, and payers communicate with one another.

For both of these reasons, we have recently taken steps to integrate our informatics work into our other substantive research centers. This step will strengthen our commitment to informatics in the long run.

Because the Secretary believes that health informatics is critical issue to the health care system, she asked me shortly after I joined the Agency to co-chair the Department-wide Data Council, which has become an increasingly important forum for decisionmaking in the area of information technology and carrying out the Department's statutory responsibilities. AHCPR's experts in informatics will help the Data Council as it addresses issues of advancing a common language for information technology systems and addressing questions of their appropriate use.

AHCPR's Medical Expenditure Panel Survey (MEPS) provides policymakers and others with up-to-date, highly detailed information on how Americans as a whole, as well as different segments of the population, use and pay for health care. This ongoing survey also looks at insurance coverage and other factors related to access to health care. MEPS is the only survey that collects expenditure data from the non-Medicare population.

MEPS data is used by Congress and Federal agencies, including HCFA and other components of the Department of Health and Human Services, Office of Management and Budget, and Department of the Treasury. If MEPS data were available during my tenure on the Physician Payment Review Commission, it would have been an invaluable source of information in helping to make recommendations to Congress on payment for physicians.

These data also are used widely in the private sector by researchers at The Heritage Foundation, Lewin-VHI, Urban Institute, RAND Corporation, and Project Hope, as well as by health insurance companies, pharmaceutical firms, and other health-related businesses.

Using MEPS data on the first 6 months of 1996, AHCPR researchers Philip F. Cooper and Barbara Steinberg Schone have found that as many as 6 million Americans choose not to accept health insurance when offered it by their employers. The study found that the number of workers declining employment-based health insurance increased by 140 percent between 1987 and 1996 while the number of employers offering health insurance increased during those years. Those most likely to turn down insurance are young (under age 25), single, Hispanic or black, and work for low wages. Possible factors driving this trend include the decline in real wages, higher employee contribution rates, and State legislation aimed at enhancing insurance coverage which may have increased costs.

AHCPR's assistance is not limited to Federal policymakers. An important AHCPR program is the User Liaison Program (ULP), which plays a critical role in providing technical assistance to States and local policymakers on a wide range of issues. For example, the ULP program conducted a workshop geared toward State policymakers to examine the latest research findings on the uninsured and what State governments have been doing to solve the problem. In 1998, the ULP will provide technical assistance to help State legislators and Executive branch officials plan for and implement the State Children's Health Insurance Program (CHIP) recently enacted by Congress.

One of AHCPR's statutory responsibilities is to conduct assessments of new technologies for the Medicare program (HCFA) and the Department of Defense. This information is invaluable to Federal policymakers and in some case drives coverage policy in the private sector. A case in point is AHCPR's technology assessment on lung volume reduction surgery (LVRS). This technology assessment concluded that there was insufficient evidence upon which to make a scientific judgment regarding the effectiveness of LVRS. AHCPR recommended that coverage be granted within the scope of a clinical trial, which is now being conducted by the National Institutes of Health. AHCPR is supporting the cost-effectiveness component of that trial. It is our hope that the collaborative efforts between the agencies will yield the information needed to make an informed coverage decision on LVRS.

AHCPR's new Evidence-based Practice Centers will continue to produce timely technology assessments that will assist Federal, State, and private sector decisionmakers make difficult coverage decisions. Private-sector policymakers also use our research to make informed health care decisions. Recently, the Pharmaceutical Research and Manufacturers of America included AHCPR's research finding on atrial fibrillation to promote the use of blood thinning drugs in an advertisement touting "three ways pharmaceuticals are ganging up against health care costs."

AHCPR's research and data give policymakers the "big picture" on the cost, use, and access to health care in this country for them to use in making decisions about clinical policy, coverage, quality improvement, and spending.


In order for health services research to fulfill its potential to improve the quality of the health care system, the foundation on which it rests must be strong. This foundation includes the tools that can be used to improve health care, the training to nurture and promote the best researchers, and the teams that foster partnerships and collaborations among the public and private sectors.

All of these elements will enable AHCPR to meet the challenges we face. Mr. Chairman and members of the Subcommittee, I respectfully request that you reauthorize AHCPR so that we can help our Nation's health care system by:

  • Conducting and supporting research on the outcomes and effectiveness of treatments.
  • Ensuring that clinicians, patients, health care system leaders, and policymakers have the information that will enhance quality of care.
  • Identifying gaps in access to and use of health care services, achieving value for the Nation's health care dollar, and
  • Helping the market find ways to fill those gaps.

These issues are critical to a sound, high quality health care system. I look forward to working with the Subcommittee in the months ahead to find ways to improve health care decisionmaking.

Privacy Notice (www.hhs.gov/Privacy.html) | FOIA (www.hhs.gov/foia/) | What's New (www.hhs.gov/about/index.html#topiclist) | FAQs (answers.hhs.gov) | Reading Room (www.hhs.gov/read/) | Site Info(www.hhs.gov/SiteMap.html)